CClinicalTrials.gg
CompletedNCT00454454DETECTUpdated Jul 30, 2013

Virtual Reality Helmet to Test for Problems With Memory

An observational study in Memory, sponsored by Emory University. Completed at 2 sites in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2013-07-30.

Sponsored by Emory University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
425
Ages
65 Years and older
Sex
All
01

Study summary

The purpose of this research study is to compare a virtual reality display device with the standard neuropsychological evaluation for detecting mild cognitive impairment (problems with memory, concentration, reaction time, etc.).

Read the detailed description

Since many individuals with mild cognitive impairment (MCI) appear to function normally, MCI may often be recognizable through testing in advance of any changes noticed by family members or caregivers. Early and frequent testing can therefore trigger an earlier diagnosis, which may increase the effectiveness of currently available medications used to delay onset of Alzheimer's symptoms. Primary care and geriatric physicians currently lack the necessary tools required for quick and accurate MCI screening in the doctor's office environment. The current industry-standard is a battery of pen \& paper neuropsychological tests that require 1.5 hours in a quiet room with a neuropsychologist.

Comparison: virtual reality display device compared to the standard neuropsychological evaluation for detecting mild cognitive impairment (problems with memory, concentration, reaction time, etc.).

02

Conditions studied

  • Memory

Keywords

  • memory
  • display enhanced testing
03

In context

Lead sponsor

Emory University is the lead sponsor of 1,386 studies on the registry; 236 are open to participants now.

Of its 229 completed or terminated interventional studies of FDA-regulated products, 174 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

geriatric clinic, retirement facilities

Inclusion criteria

  • 65 yrs of age and older
  • MMSE of 18 or greater or mini-cog of 4 or greater
  • Ability to read
  • Informed consent given

Exclusion criteria

Exclusion Criteria:

  • Visual, hearing or physical impairment that would limit ability to use the virtual reality helmet or control device
  • Non-English speaking
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
425 participants (actual)

Groups and cohorts

  • No treatment
06

Study locations

2 sites
  • Wesley Woods Health Center
    Atlanta, Georgia 30322, United States
  • Wesley Woods Outpatient Clinic
    Atlanta, Georgia 30322, United States
07

References and documents

Publications

  • Wright DW, Nevarez H, Kilgo P, LaPlaca M, Robinson A, Fowler S, Brumfield J, Goldstein FC. A novel technology to screen for cognitive impairment in the elderly. Am J Alzheimers Dis Other Demen. 2011 Sep;26(6):484-91. doi: 10.1177/1533317511426133. Epub 2011 Nov 22. PubMed 22110158 ↗
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 30, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00454454
Lead sponsor
Emory University
Collaborators
Wallace H. Coulter Foundation
Responsible party
David Wright (Associate Professor, Emory University) — Principal investigator
First posted
Mar 30, 2007
Start date
Mar 2007
Primary completion
Jul 2010
Completion
Jul 2010
Last update
Jul 30, 2013

Study contacts

David W Wright, MD
principal investigator · Emory University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion